BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30546445)

  • 1. Racial disparities in the survival time of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma between Chinese patients and patients of other racial groups: A population-based study from 2004 to 2013.
    Ren F; Zhang J; Gao Z; Zhu H; Chen X; Liu W; Xue Z; Gao W; Wu R; Lv Y; Hu L
    Oncol Lett; 2018 Dec; 16(6):7102-7116. PubMed ID: 30546445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.
    Xu L; Kim Y; Spolverato G; Gani F; Pawlik TM
    Hepatobiliary Surg Nutr; 2016 Feb; 5(1):43-52. PubMed ID: 26904556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
    Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
    Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased morbidity and mortality of hepatocellular carcinoma patients in lower cost of living areas.
    Sempokuya T; Patel KP; Azawi M; Ma J; Wong LL
    World J Clin Cases; 2021 Aug; 9(23):6734-6746. PubMed ID: 34447820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma.
    Sempokuya T; Wien EA; Pattison RJ; Ma J; Wong LL
    World J Hepatol; 2020 Nov; 12(11):1020-1030. PubMed ID: 33312426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry.
    Stenzel AE; Buas MF; Moysich KB
    Cancer Epidemiol; 2019 Oct; 62():101580. PubMed ID: 31400533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival differences in nasopharyngeal carcinoma among racial and ethnic minority groups in the United States: A retrospective cohort study.
    Challapalli SD; Simpson MC; Adjei Boakye E; Walker RJ; Antisdel JL; Ward GM; Osazuwa-Peters N
    Clin Otolaryngol; 2019 Jan; 44(1):14-20. PubMed ID: 30216675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of patients with hepatocellular carcinoma in the San Joaquin Valley: a comparison with California Cancer Registry data.
    Atla PR; Sheikh MY; Mascarenhas R; Choudhury J; Mills P
    Ann Gastroenterol; 2012; 25(2):138-146. PubMed ID: 24714222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
    Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
    Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma.
    Mokdad AA; Murphy CC; Pruitt SL; Mansour JC; Marrero JA; Singal AG; Yopp AC
    Cancer; 2018 Feb; 124(4):743-751. PubMed ID: 29072773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma.
    O'Malley CD; Prehn AW; Shema SJ; Glaser SL
    Cancer; 2002 Jun; 94(11):2836-43. PubMed ID: 12115370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Differences in the Overall Survival of Hairy Cell Leukemia in the United States: A Population-Based Analysis of the Surveillance, Epidemiology, and End Results Database.
    Giri S; Shrestha R; Pathak R; Bhatt VR
    Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):484-8. PubMed ID: 25882766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
    Roche AM; Fedewa SA; Chen AY
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased long-term survival among patients with hepatocellular carcinoma after implementation of Model for End-stage Liver Disease score.
    Wong RJ; Devaki P; Nguyen L; Cheung R; Cho-Phan C; Nguyen MH
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1534-40.e1. PubMed ID: 24361414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
    Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry.
    Stenzel AE; Fenstermaker RA; Wiltsie LM; Moysich KB
    J Neurooncol; 2019 Aug; 144(1):43-51. PubMed ID: 31209774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.